(Q26782582)

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Common variants in MODY genes increase the risk of gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

The impact of ethnicity on glucose homeostasis after gestational diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Criteria for screening tests for gestational diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Maturity onset diabetes of the young and pregnancy

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Animal evidence for the transgenerational development of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Poor prognosis of pregnancy in women with autoimmune type 1 diabetes mellitus masquerading as gestational diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Definition, epidemiology, risk factors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Are third-trimester adipokines associated with higher metabolic risk among women with gestational diabetes?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Evaluation of the International Association of the Diabetes In Pregnancy Study Group new criteria: gestational diabetes project

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Maternal diabetes mellitus and infant malformations

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Effect of a diabetic environment in utero on predisposition to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

When should we screen for gestational diabetes?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Molecular Genetics of Maturity-onset Diabetes of the Young

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Mutations in the glucokinase gene of the fetus result in reduced birth weight

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

A comparison of glyburide and insulin in women with gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Effect of treatment of gestational diabetes mellitus on pregnancy outcomes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Metformin versus insulin for the treatment of gestational diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Hyperglycemia and adverse pregnancy outcomes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Pregnancy and insulin resistance.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Association between gestational diabetes and pregnancy-induced hypertension.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Trying to understand gestational diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Prevalence and features of pancreatic islet cell autoimmunity in women with gestational diabetes from different ethnic groups

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Poor birth weight recovery among low birth weight/preterm infants following hospital discharge in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Increased methylation at differentially methylated region of GNAS in infants born to gestational diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Modulation of adipokines and cytokines in gestational diabetes and macrosomia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Common Type 2 Diabetes Risk Gene Variants Associate with Gestational Diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Maternal pregravid weight is the primary determinant of serum leptin and its metabolic associations in pregnancy, irrespective of gestational glucose tolerance status.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Diurnal variation in insulin sensitivity of glucose metabolism is associated with diurnal variations in whole-body and cellular fatty acid metabolism in metabolically normal women

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Role of gestational hormones in the induction of insulin resistance.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Positive outcomes influence the rate and time to publication, but not the impact factor of publications of clinical trial results

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Prevalence of gestational diabetes and associated maternal and neonatal complications in a fast-developing community: global comparisons

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Genetics of gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: common genetic variants in GCK and TCF7L2 are associated with fasting and postchallenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Fetal exposure to maternal type 1 diabetes is associated with renal dysfunction at adult age.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

What is gestational diabetes?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Defining and characterizing the progression of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Hepatic insulin resistance is an early determinant of declining β-cell function in the first year postpartum after glucose intolerance in pregnancy

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Diagnostic and prognostic performances over 9 years of a selective screening strategy for gestational diabetes mellitus in a cohort of 18,775 subjects.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Diagnosis and classification of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Each degree of glucose intolerance in pregnancy predicts distinct trajectories of β-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Gestational diabetes mellitus. Heterogeneity of maternal age, weight, insulin secretion, HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Insulin action during pregnancy. Studies with the euglycemic clamp technique.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

TNF-alpha is a predictor of insulin resistance in human pregnancy

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Lipid levels in former gestational diabetic mothers

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Screening for MODY mutations, GAD antibodies, and type 1 diabetes--associated HLA genotypes in women with gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Diabetes and abnormal glucose tolerance in women with previous gestational diabetes

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Gestational Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021

Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0378

7 January 2021